BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of 199.42 billion as of June 27, 2025. Its market cap has decreased by -21.63% in one year.

Market Cap

199.42B

Enterprise Value

186.79B

Revenue

60.30B

Ranking

n/a

PE Ratio

18.62

Stock Price

1,059.00

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 4.20B to 199.42B, an increase of 4,643.84%. That is a compound annual growth rate of 16.05%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	201.28B	-22.89%
Dec 31, 2024	261.03B	-14.99%
Dec 29, 2023	307.05B	-18.16%
Dec 30, 2022	375.17B	12.82%
Dec 31, 2021	332.53B	4.98%
Dec 31, 2020	316.75B	10.58%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	1,096.67B
Grupo Financiero Banorte	477.64B
Arca Continental	335.61B
Industrias Peñoles	191.37B
GMéxico Transportes	142.90B
FIBRA Prologis	111.33B
Fibra UNO	98.94B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	88.71B

Market Cap Rankings